John E. Hesketh

Fondatore presso Uni Targeting Research AS

Consumer Services

Health Technology

Profilo

John E.
Hesketh is the founder of Uni Targeting Research AS, which was founded in 2001, where he holds the title of Principal.
Currently, he holds the position of Professor at Newcastle University and the position of Principal at the University of Natural Resources & Life Sciences.

Posizioni attive di John E. Hesketh

Società	Posizione	Inizio
Uni Targeting Research AS Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.	Fondatore	30/07/2009
Newcastle University	Corporate Officer/Principal	28/07/2009
University of Natural Resources & Life Sciences	Corporate Officer/Principal	-

Tutte le posizioni attive di John E. Hesketh

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di John E. Hesketh

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Uni Targeting Research AS Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway.	Health Technology